Greenleaf Trust’s Fabrinet FN Stock Holding History

Greenleaf Trust’s Portfolio FN Stock Details FN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Sell	404 -4	-1%	-$2.58K	﹤0.01%	792
2026 Q1	$213K	Buy	+408	New	+$207K	﹤0.01%	757

Other funds holding FN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Greenleaf Trust's FN Position: Q2 2026 in Review

Greenleaf Trust reduced its Fabrinet (FN) stake by 0.98% in Q2 2026, selling an estimated $2.58K and leaving 404 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Greenleaf Trust first reported a position in FN in Q1 2026 and has held it in 2 quarters since. 756 funds tracked by Wall St. Rank hold FN as of Q2 2026.

Greenleaf Trust held 404 shares of Fabrinet worth $227K as of Q2 2026.
Greenleaf Trust sold 4 Fabrinet shares in Q2 2026, an estimated $2.58K.
Fabrinet made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #792 holding.
Greenleaf Trust first reported a position in Fabrinet in Q1 2026 and has held it in 2 quarters since.
756 funds tracked by Wall St. Rank held Fabrinet as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.